EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Features of CFTR mRNA and implications for therapeutics development

JaNise J Jackson, Yiyang Mao, Tyshawn R White, Catherine Foye, Kathryn E Oliver

Frontiers in Genetics · 24.04.2023 · 14

DOI: 10.3389/fgene.2023.1166529 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Frontiers in Genetics, online erschienen am 24.04.2023. Verfasst von JaNise J Jackson und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Emory University School of Medicine, Atlanta, GA, United States. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 119 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NHLBI NIH HHS, National Institutes of Health, Cystic Fibrosis Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cystic fibrosis (CF) is an autosomal recessive disease impacting ∼100,000 people worldwide. This lethal disorder is caused by mutation of the CF transmembrane conductance regulator (CFTR) gene, which encodes an ATP-binding cassette-class C protein. More than 2,100 variants have been identified throughout the length of CFTR . These defects confer differing levels of severity in mRNA and/or protein synthesis, folding, gating, and turnover. Drug discovery efforts have resulted in recent development of modulator therapies that improve clinical outcomes for people living with CF. However, a significant portion of the CF population has demonstrated either no response and/or adverse reactions to small molecules. Additional therapeutic options are needed to restore underlying genetic defects for all patients, particularly individuals carrying rare or refractory CFTR variants. Concerted focus has been placed on rescuing variants that encode truncated CFTR protein, which also harbor abnormalities in mRNA synthesis and stability. The current mini-review provides an overview of CFTR mRNA features known to elicit functional consequences on final protein conformation and function, including considerations for RNA-directed therapies under investigation. Alternative exon usage in the 5′-untranslated region, polypyrimidine tracts, and other sequence elements that influence splicing are discussed. Additionally, we describe mechanisms of CFTR mRNA decay and post-transcriptional regulation mediated through interactions with the 3′-untranslated region (e.g. poly-uracil sequences, microRNAs). Contributions of synonymous single nucleotide polymorphisms to CFTR transcript utilization are also examined. Comprehensive understanding of CFTR RNA biology will be imperative for optimizing future therapeutic endeavors intended to address presently untreatable forms of CF.

Schlagwörter

Stichwörter der Autor:innen

CFTRantisense oligonucleotidemRNA stabilitymiRNApeptide nucleic acid (PNA)readthrough compoundsuppressor tRNAsynonymous single nucleotide polymorphism

Autor:innen und Institutionen

  • Department of Pediatrics, Emory University School of Medicine, Atlanta, GA, United States.
  • Center for Cystic Fibrosis and Airways Disease Research, Emory University and Children's Healthcare of Atlanta, Atlanta, GA, United States.

Förderung

  • NHLBI NIH HHS
  • National Institutes of Health
  • Cystic Fibrosis Foundation

Zitieren

APA

Jackson, J. J., Mao, Y., White, T. R., Foye, C., & Oliver, K. E. (2023). Features of CFTR mRNA and implications for therapeutics development. Frontiers in Genetics, 14. https://doi.org/10.3389/fgene.2023.1166529

Vancouver

Jackson JJ, Mao Y, White TR, Foye C, Oliver KE. Features of CFTR mRNA and implications for therapeutics development. Frontiers in Genetics. 2023;14. doi:10.3389/fgene.2023.1166529

BibTeX
@article{Jackson2023,
  author = {Jackson, JaNise J and Mao, Yiyang and White, Tyshawn R and Foye, Catherine and Oliver, Kathryn E},
  title = {Features of CFTR mRNA and implications for therapeutics development},
  journal = {Frontiers in Genetics},
  year = {2023},
  volume = {14},
  doi = {10.3389/fgene.2023.1166529}
}
Kostenlos starten →